“I'm absolutely delighted to share my outstanding experience with Gencefe Biotech. From the moment I engaged with them, they have consistently exceeded my expectations in multiple aspects. 

Wuxi, China – GenCefe Biotech is proud to announce that it has successfully obtained ISO 13485 certification, a globally recognized standard for quality management systems in the medical device and biotechnology industries. This milestone demonstrates the company’s unwavering commitment to delivering high-quality, reliable, and innovative solutions to its customers worldwide. 

[Wuxi, July 1st, 2024]: GenCefe Biotech Co., Ltd., a leading provider of Oligonucleotide, Gene, and Protein Synthesis Services, is pleased to announce the signing of an exclusive distributor agreement with Medsol Corporation, a medical equipment and chemical reagents distributor which has been operating since 2014 with HQ in Cairo, Egypt and other branches in Riyadh - KSA, Dubai - UAE, Rabat - Morrocco in addition to other 8 countries over the MENA region. This strategic partnership aims to expand GenCefe's presence and strengthen its market position in Egypt.

[Wuxi, April 16th , 2024]: GenCefe Biotech Co., Ltd., a leading provider of Oligonucleotide, Gene, and Protein Synthesis Services, is pleased to announce the signing of an exclusive distributor agreement with Bionics , a prominent supplier in equipment, biochemicals, and molecular biology products. This strategic partnership aims to expand GenCefe's presence and strengthen its market position in Pakistan .

[Wuxi, April 08, 2024]: GenCefe Biotech Co., Ltd., a leading provider of Oligonucleotide, Gene, and Protein Synthesis Services, is pleased to announce the signing of an exclusive distributor agreement with Prodotti Gianni Srl, a prominent supplier in pharmaceutical, cosmetic, agri-food and life science markets. This strategic partnership aims to expand GenCefe's presence and strengthen its market position in Italy.